Topic: Pfizer Profits

6 chapters across the catalog

chatJCD
Episode 1788 26:54 - 33:02

1788: chatJCD

Media Response to Vaccine Funding Cuts

Major news networks reported on the $500 million funding cut, highlighting that the targeted projects were led by Pfizer and Moderna. Critics question why profitable pharmaceutical giants require taxpayer subsidies for research. Dr. Celine Gounder appeared on CBS to defend mRNA technology as a vital tool for rapid pandemic response.

Bay Gin
Episode 1532 1:07:49 - 1:13:40

1532: Bay Gin

Project Veritas Leadership Crisis, James O'Keefe Ouster

An in-depth look at the internal conflict at Project Veritas following the release of a video by James O'Keefe. The segment includes exclusive updates from a producer serving as the organization's executive director, who disputes claims that O'Keefe was formally fired or resigned.

Red Queen
Episode 1530 1:10:19 - 1:13:26

1530: Red Queen

Project Veritas Internal Management and James O'Keefe Status

Project Veritas Executive Director Daniel Strack issued a public statement clarifying that James O'Keefe has not been removed from the organization. The statement addressed a leaked internal letter regarding management concerns and staff treatment, characterizing the narrative of a Pfizer-led coup as false. Strack emphasized that the board consists of long-term donors who support O'Keefe's mission.

Green Transition
Episode 1454 1:12:58 - 1:15:51

1454: Green Transition

Pfizer Accord for a Healthier World, ESG Initiatives

Pfizer launched the "Accord for a Healthier World" to provide patented medicines to 45 lower-income countries on a non-profit basis. Bill Gates explains that such initiatives are part of a broader Environmental, Social, and Governance (ESG) effort to keep pharmaceutical companies investable.

Sour Crude
Episode 1402 1:15:51 - 1:18:12

1402: Sour Crude

Pfizer Profits, Moderna Sales, mRNA Market

Pfizer expects to earn $36 billion from COVID-19 vaccine sales this year, potentially breaking the record for a single pharmaceutical product previously held by Humira. Moderna is projected to reach $18 billion in sales. Analysts discuss the uncertainty of long-term mRNA revenue and the industry's current focus on maximizing sales through booster shots.

Inflation Demon
Episode 1395 53:06 - 55:37

1395: Inflation Demon

Pfizer Business Practices, WION Report and Vaccine Terrorism

The Indian news outlet WION reported on what it characterizes as "vaccine terrorism" and bullying by Pfizer against sovereign governments. The report alleges the pharmaceutical giant prioritizes profit over public good by silencing governments and halting supplies to secure favorable terms. This behavior is linked to a long-term industry shift toward mRNA technology and the pursuit of vaccines for non-communicable issues like addiction, all while maintaining legal immunity from lawsuits.